To address the challenges in producing these biomolecules, WuXi Biologics has introduced the EffiX™ platform, which enables the development and manufacturing of microbial-derived biologics with high ...

Try Now>> See the top stocks recommended by analysts >> Read More on ADMA: ADMA Biologics NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

These highly potent compounds are crucial for the development of cancer drugs and biologics, where precise formulations and dose control are essential due to their potent pharmacological effects.

WUXI, China, Feb. 27, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has ...

WUXI, China, Feb. 26, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization ...